Daniella Beckman
Director of Finance/CFO chez TANGO THERAPEUTICS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Daniella Beckman is currently an Independent Director at Blueprint Medicines Corp.
and Vor Biopharma, Inc. She also holds the position of Chief Financial Officer at Tango Therapeutics Sub, Inc. and Tango Therapeutics, Inc. In the past, she served as CFO, Treasurer, Director & Vice President at Idenix Pharmaceuticals LLC from 2011 to 2014.
She was also an Independent Director at Translate Bio, Inc. from 2017 to 2021 and at 5:01 Acquisition Corp.
from 2020 to 2022.
Additionally, she worked as the Chief Financial Officer at BioNTech US, Inc. from 2015 to 2019 and at Beckman Consulting LLC from 2015 to 2019.
Ms. Beckman completed her undergraduate degree at Boston University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TANGO THERAPEUTICS, INC.
0,12% | 07/02/2024 | 132 397 ( 0,12% ) | 1 M $ | 31/03/2024 |
| 21/06/2023 | 8 600 ( 0,01% ) | 815 796 $ | 31/03/2024 | |
VOR BIOPHARMA, INC.
-.--% | 26/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Daniella Beckman
| Sociétés | Poste | Début |
|---|---|---|
| VOR BIOPHARMA INC. | Director/Board Member | 16/07/2020 |
| TANGO THERAPEUTICS, INC. | Director of Finance/CFO | 01/10/2016 |
| BLUEPRINT MEDICINES CORPORATION | Director/Board Member | 08/12/2021 |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 01/09/2019 |
Anciens postes connus de Daniella Beckman
| Sociétés | Poste | Fin |
|---|---|---|
| 501 ACQU | Director/Board Member | 01/01/2022 |
| TRANSLATE BIO, INC. | Director/Board Member | 14/09/2021 |
| NEON THERAPEUTICS, INC. | Director of Finance/CFO | 01/09/2019 |
Beckman Consulting LLC
 Beckman Consulting LLC Miscellaneous Commercial ServicesCommercial Services Beckman Consulting LLC provides consulting services. The private company is based in Boston. | Director of Finance/CFO | 01/09/2019 |
| IDENIX PHARMACEUTICALS INC | Director of Finance/CFO | 01/08/2014 |
Formation de Daniella Beckman
| Boston University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| TANGO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
BioNTech US, Inc.
 BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Health Technology |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance 5:01 Acquisition Corp. is a blank check emerging growth company that was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 31, 2020 and is headquartered in San Francisco, CA. | Finance |
Beckman Consulting LLC
Beckman Consulting LLC Miscellaneous Commercial ServicesCommercial Services Beckman Consulting LLC provides consulting services. The private company is based in Boston. | Commercial Services |
